Skye Bioscience Inc (SKYE)

[cjarmstrong]

OK, but this is the last time. There's nothing fraudulent about Nemus, and it wasn't a pump and dump. In the last 2+ years only one insider has sold, and he's a still a 10% shareholder. How exactly would Dhillon (not Dillon) steal Murphy and "his" CBD analogue? You mean the IP licensed to Nemus? Emerald is cleaning house, if they don't RTO and just want a controlling interest I think Murphy will be replaced as CEO anyway. I told you that Insys passed (at the time I didn't know it was Insys) - because they went sublingual. That was before UofM created a transmucosal patch which I'm sure is what Emerald is really interested in regarding NB1222/NB2111. No evidence Mallincrockdt (who I also told you about) was interested in a new molecule or even biosynthetic THC. It sounds like they were only interested in making generic dronabinol.

Speaking of Zynerba doing things the right way, their open label FXS data is completely useless, now they have to do a double blind placebo controlled trial.